Dehydroemetine

Dehydroemetine
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	P01AX09 (WHO) ;
Identifiers
	IUPAC name (11bS)-2-[[(1R)-6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-4,6,7,11b-tetrahydro-1H-pyrido[2,1-a]isoquinoline;
CAS Number	4914-30-1 ;
PubChem CID	21022;
ChemSpider	19773 ;
UNII	7S79QT1T91;
KEGG	D00828 ;
ChEBI	CHEBI:4363;
ChEMBL	ChEMBL547470 ;
CompTox Dashboard (EPA)	DTXSID901023600 ;
ECHA InfoCard	100.023.220
Chemical and physical data
Formula	C29H38N2O4
Molar mass	478.633 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O(c1cc2c(cc1OC)[C@H](NCC2)CC\5=C(/CC)CN4[C@H](c3c(cc(OC)c(OC)c3)CC4)C/5)C;
	InChI InChI=1S/C29H38N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,24-25,30H,6-12,17H2,1-5H3/t24-,25+/m1/s1 ; Key:XXLZPUYGHQWHRN-RPBOFIJWSA-N ;
	(what is this?) (verify)

Dehydroemetine is a synthetically produced antiprotozoal agent similar to emetine in its anti-amoebic properties and structure (they differ only in a double bond next to the ethyl substituent), but it produces fewer side effects. In the United States, it is manufactured by Roche.